Abstract
The gene for dihydrofolate reductase of Mycobacterium tuberculosis was amplified by polymerase chain reaction (PCR) from M. tuberculosis H37Rv strain genomic DNA. The protein was expressed in inclusion bodies in high yield in Escherichia coli under the control of the T7 promoter. Active enzyme was obtained by refolding from guanidine HCl and after a single chromatography step the sample was > 99% homogeneous with a specific activity of approximately 15.5 micromol min(-1) mg(-1). Mass spectrometry analysis confirmed the expected mass of 17.6 kDa. Gel filtration of the enzyme indicated that it was a monomer. Steady-state kinetic parameters were determined and the effect of pH and KCl on the enzyme examined. Methotrexate and trimethoprim inhibited the enzyme.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Amino Acid Sequence
-
Chromatography, Liquid
-
Cloning, Molecular
-
Enzyme Inhibitors / pharmacology
-
Enzyme Stability
-
Escherichia coli / enzymology
-
Escherichia coli / genetics
-
Hydrogen-Ion Concentration
-
Methotrexate / pharmacology
-
Molecular Sequence Data
-
Molecular Weight
-
Mycobacterium tuberculosis / enzymology*
-
Mycobacterium tuberculosis / genetics*
-
Potassium Chloride
-
Recombinant Proteins / biosynthesis
-
Sequence Alignment
-
Tetrahydrofolate Dehydrogenase / chemistry
-
Tetrahydrofolate Dehydrogenase / genetics*
-
Tetrahydrofolate Dehydrogenase / isolation & purification
-
Tetrahydrofolate Dehydrogenase / metabolism*
-
Trimethoprim / pharmacology
Substances
-
Enzyme Inhibitors
-
Recombinant Proteins
-
Potassium Chloride
-
Trimethoprim
-
Tetrahydrofolate Dehydrogenase
-
Methotrexate